Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HemaSphere

Showing results (1-10 of 1,331) with videos related to

Pageof 134
Sort By:
Hemasphere|December 8, 2022
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA TrialFriederike Braulke, Florian Zettl, Marita Ziepert, et al.
Hemasphere|December 8, 2022
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical PracticeMichel Delforge, Marie-Christiane Vekemans, Julien Depaus, et al.
Hemasphere|October 16, 2020
Control of Systemic Iron Homeostasis by the 3' Iron-Responsive Element of Divalent Metal Transporter 1 in MiceElisabeth Tybl, Hiromi Gunshin, Sanjay Gupta, et al.
Hemasphere|July 15, 2021
Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world PerspectiveStefan Hatzl, Peter Kalmar, Florian Posch, et al.
Hemasphere|June 16, 2021
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab TreatmentMichele Clerico, Irene Dogliotti, Andrea Calcagno, et al.
Hemasphere|June 16, 2021
JAM-C/<i>Jam-C</i> Expression Is Primarily Expressed in Mouse Hematopoietic Stem CellsElia Henry, Vilma Barroca, Cécile K Lopez, et al.
Hemasphere|June 12, 2023
High Hospital-related Costs at the End-of-life in Patients With Multiple Myeloma: A Single-center StudyChristine Bennink, Hans Westgeest, Daan Schoonen, et al.
Hemasphere|June 12, 2023
Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma CellsJudith Mateos-Jaimez, Maurizio Mangolini, Anna Vidal, et al.
Hemasphere|December 16, 2020
Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell TransplantationEleni Gavriilaki, Ioanna Sakellari, Thomas Chatzikonstantinou, et al.
Hemasphere|December 16, 2020
Introduction of Biosimilar Rituximab: A Hospital PerspectiveSimon Cheesman
Pageof 134

Showing results (1-10 of 1,331) with videos related to

Sort By:
Pageof 134
Hemasphere|December 8, 2022
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA TrialFriederike Braulke, Florian Zettl, Marita Ziepert, et al.
Hemasphere|December 8, 2022
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical PracticeMichel Delforge, Marie-Christiane Vekemans, Julien Depaus, et al.
Hemasphere|October 16, 2020
Control of Systemic Iron Homeostasis by the 3' Iron-Responsive Element of Divalent Metal Transporter 1 in MiceElisabeth Tybl, Hiromi Gunshin, Sanjay Gupta, et al.
Hemasphere|July 15, 2021
Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world PerspectiveStefan Hatzl, Peter Kalmar, Florian Posch, et al.
Hemasphere|June 16, 2021
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab TreatmentMichele Clerico, Irene Dogliotti, Andrea Calcagno, et al.
Hemasphere|June 16, 2021
JAM-C/<i>Jam-C</i> Expression Is Primarily Expressed in Mouse Hematopoietic Stem CellsElia Henry, Vilma Barroca, Cécile K Lopez, et al.
Hemasphere|June 12, 2023
High Hospital-related Costs at the End-of-life in Patients With Multiple Myeloma: A Single-center StudyChristine Bennink, Hans Westgeest, Daan Schoonen, et al.
Hemasphere|June 12, 2023
Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma CellsJudith Mateos-Jaimez, Maurizio Mangolini, Anna Vidal, et al.
Hemasphere|December 16, 2020
Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell TransplantationEleni Gavriilaki, Ioanna Sakellari, Thomas Chatzikonstantinou, et al.
Hemasphere|December 16, 2020
Introduction of Biosimilar Rituximab: A Hospital PerspectiveSimon Cheesman
Pageof 134